Title |
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS |
|---|---|
Involved |
for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) (Verfasser)
G. J. Ossenkoppele (Verfasser) D. A. Breems (Verfasser) G. Stuessi (Verfasser)
Y. van Norden (Verfasser)
M. Bargetzi (Verfasser) B. J. Biemond (Verfasser) P. A von dem Borne (Verfasser) Y. Chalandon (Verfasser) J. Cloos (Verfasser) D. Deeren (Verfasser) M. Fehr (Verfasser) B. Gjertsen (Verfasser) C. Graux (Verfasser) G. Huls (Verfasser) J. J. J. W. Janssen (Verfasser) A. Jaspers (Verfasser) M. Jongen-Lavrencic (Verfasser) E. de Jongh (Verfasser) S. K. Klein (Verfasser) M. van der Klift (Verfasser) M. van Marwijk Kooy (Verfasser) J. Maertens (Verfasser) L. Michaux (Verfasser) M. W. M. van der Poel (Verfasser) A. van Rhenen (Verfasser) L. Tick (Verfasser) P. Valk (Verfasser) M. C. Vekemans (Verfasser) W. J. F. M. van der Velden (Verfasser) O. de Weerdt (Verfasser) T. Pabst (Verfasser) Markus G. Manz (Verfasser) B. Löwenberg (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Leukemia : normal and malignant hemopoiesis ; a peer-reviewed journal 34, 10, 30.7.2020, date:10.2020, Seite 2820 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Medicine/Public Health, general.
Internal Medicine. Intensive / Critical Care Medicine. Cancer Research.
Oncology.
Hematology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2022080621220595182990 (URN) |
Record ID |
1264702213 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: